SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
2.100
-0.020 (-0.94%)
Aug 28, 2025, 4:00 PM - Market closed

SAB Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
-37.06-34.11-42.19-18.74-17.1420.12
Upgrade
Depreciation & Amortization
3.314.793.753.291.650.55
Upgrade
Loss (Gain) From Sale of Assets
--0.04-0.02-0.01-0
Upgrade
Loss (Gain) From Sale of Investments
-0.24-0.24----
Upgrade
Stock-Based Compensation
2.962.942.422.672.311.3
Upgrade
Other Operating Activities
-1.97-5.398.53-10.433.49-
Upgrade
Change in Accounts Receivable
--5.562.4512.56-17.75
Upgrade
Change in Accounts Payable
1.550.92-2.7-0.78-2.945.21
Upgrade
Change in Unearned Revenue
-0.11-1.321.32-0.1-0.1
Upgrade
Change in Other Net Operating Assets
0.79-1.9-1.85-1.812.060.48
Upgrade
Operating Cash Flow
-30.77-34.29-25.12-23.461.9910
Upgrade
Operating Cash Flow Growth
-----80.14%-
Upgrade
Capital Expenditures
-0.16-0.34-0.2-2.17-10.94-12.73
Upgrade
Sale of Property, Plant & Equipment
0-0.040.08-0.01
Upgrade
Investment in Securities
18.2-11.63----
Upgrade
Investing Cash Flow
18.05-11.96-0.15-2.09-10.94-12.72
Upgrade
Long-Term Debt Issued
-0.520.771.242.840.66
Upgrade
Short-Term Debt Repaid
------1.36
Upgrade
Long-Term Debt Repaid
--1.42-1.16-2.42-1.3-0.21
Upgrade
Total Debt Repaid
-1.27-1.42-1.16-2.42-1.3-1.58
Upgrade
Net Debt Issued (Repaid)
-0.75-0.91-0.39-1.191.54-0.92
Upgrade
Issuance of Common Stock
-0.0259.667.760.019.9
Upgrade
Repurchase of Common Stock
-0.03-0.02----
Upgrade
Other Financing Activities
-0.03-0.26--5.5234.34-
Upgrade
Financing Cash Flow
-0.8-1.1766.771.0535.898.98
Upgrade
Foreign Exchange Rate Adjustments
-0.02-0.240.02---
Upgrade
Net Cash Flow
-13.55-47.6741.52-24.526.936.26
Upgrade
Free Cash Flow
-30.93-34.63-25.32-25.63-8.96-2.73
Upgrade
Free Cash Flow Margin
-26965.30%-2618.65%-1130.71%-107.20%-14.71%-4.94%
Upgrade
Free Cash Flow Per Share
-3.33-3.74-4.58-5.89-3.28-1.01
Upgrade
Cash Interest Paid
0.360.370.250.29--
Upgrade
Cash Income Tax Paid
---0.03--
Upgrade
Levered Free Cash Flow
-18.17-22.1-17.95-14.293.28-10.5
Upgrade
Unlevered Free Cash Flow
-17.99-21.91-17.75-14.13.46-10.21
Upgrade
Change in Working Capital
2.22-2.32.33-0.2411.68-11.95
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q